Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Clinical and Translational Medicine
|
October 3, 2025
Cardiomyocyte USP20 alleviates septic cardiomyopathy by deubiquitinating and inhibiting NLRP3 activity
Shanshan Dai, Yucong Zhang, Ziyi Huang, et al.
Basic Research in Cardiology
|
October 2, 2023
Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation
Lingfeng Zhong, Jibo Han, Xiaoxi Fan, et al.
Journal of Inflammation Research
|
November 11, 2024
GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling Pathway
Xiaoxi Fan, Wenli Zhang, Ruihan Zheng, et al.
British Journal of Pharmacology
|
April 1, 2025
GI-Y2, a novel gasdermin D inhibitor, attenuates sepsis-induced myocardial dysfunction by inhibiting gasdermin D-mediated pyroptosis in macrophages
Yiling Mei, Xudong Chen, Si Shi, et al.
International Journal of Biological Macromolecules
|
April 1, 2026
Ubiquitin-specific protease 20(USP20) mitigates doxorubicin-induced cardiotoxicity by deubiquitinating and stabilizing HuR
Yunxuan Chen, Shuoning Wu, Lang Deng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
October 6, 2023
Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD
Shanshan Dai, Yunxuan Chen, Xiaoxi Fan, et al.
BMC Public Health
|
March 2, 2022
Assessing the depression risk in the U.S. adults using nomogram
Yafeng Zhang, Wei Tian, Xinhao Han, et al.
European Journal of Pharmacology
|
July 27, 2025
Novel GSDMD inhibitor GI-Y1 attenuates sepsis-induced myocardial dysfunction by targeting Gasdermin D and inhibiting Gasdermin D-mediated pyroptosis
Si Shi, Ruihan Zheng, Li Luo, et al.
Clinical and Translational Medicine
|
March 5, 2025
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosis
Xiaoxi Fan, Zhenfeng Cheng, Ruiyin Shao, et al.
Cardiovascular Drugs and Therapy
|
December 23, 2024
Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis
Bozhi Ye, Xueli Cai, Xiaohe Liang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Clinical and Translational Medicine
|
October 3, 2025
Cardiomyocyte USP20 alleviates septic cardiomyopathy by deubiquitinating and inhibiting NLRP3 activity
Shanshan Dai, Yucong Zhang, Ziyi Huang, et al.
Basic Research in Cardiology
|
October 2, 2023
Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation
Lingfeng Zhong, Jibo Han, Xiaoxi Fan, et al.
Journal of Inflammation Research
|
November 11, 2024
GSDMD Mediates Ang II-Induced Hypertensive Nephropathy by Regulating the GATA2/AQP4 Signaling Pathway
Xiaoxi Fan, Wenli Zhang, Ruihan Zheng, et al.
British Journal of Pharmacology
|
April 1, 2025
GI-Y2, a novel gasdermin D inhibitor, attenuates sepsis-induced myocardial dysfunction by inhibiting gasdermin D-mediated pyroptosis in macrophages
Yiling Mei, Xudong Chen, Si Shi, et al.
International Journal of Biological Macromolecules
|
April 1, 2026
Ubiquitin-specific protease 20(USP20) mitigates doxorubicin-induced cardiotoxicity by deubiquitinating and stabilizing HuR
Yunxuan Chen, Shuoning Wu, Lang Deng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
October 6, 2023
Emodin attenuates cardiomyocyte pyroptosis in doxorubicin-induced cardiotoxicity by directly binding to GSDMD
Shanshan Dai, Yunxuan Chen, Xiaoxi Fan, et al.
BMC Public Health
|
March 2, 2022
Assessing the depression risk in the U.S. adults using nomogram
Yafeng Zhang, Wei Tian, Xinhao Han, et al.
European Journal of Pharmacology
|
July 27, 2025
Novel GSDMD inhibitor GI-Y1 attenuates sepsis-induced myocardial dysfunction by targeting Gasdermin D and inhibiting Gasdermin D-mediated pyroptosis
Si Shi, Ruihan Zheng, Li Luo, et al.
Clinical and Translational Medicine
|
March 5, 2025
The novel GSDMD inhibitor GI-Y2 exerts antipyroptotic effects to reduce atherosclerosis
Xiaoxi Fan, Zhenfeng Cheng, Ruiyin Shao, et al.
Cardiovascular Drugs and Therapy
|
December 23, 2024
Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis
Bozhi Ye, Xueli Cai, Xiaohe Liang, et al.
Page
of 8